39 related articles for article (PubMed ID: 12949934)
1. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people.
Acevedo C; Opazo JL; Huidobro C; Cabezas J; Iturrieta J; Quiñones Sepúlveda L
Prostate; 2003 Oct; 57(2):111-7. PubMed ID: 12949934
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of CYP1A1, GSTM1 and P53 genes in a unique Siberian population of Tundra Nentsi and its pharmacogenetic importance.
Duzhak TG; Osipova LP; Posukh OL; Chasovnikova OB; Ostashevskii VI; Lyakhovich VV
Int J Circumpolar Health; 2001 Apr; 60(2):228-34. PubMed ID: 11507974
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism analysis of the CYP1A1 locus in Koreans: presence of the solitary m2 allele.
Kim KS; Ryu SW; Kim YJ; Kim E
Mol Cells; 1999 Feb; 9(1):78-83. PubMed ID: 10102576
[TBL] [Abstract][Full Text] [Related]
4. Convergent network effects along the axis of gene expression during prostate cancer progression.
Charmpi K; Guo T; Zhong Q; Wagner U; Sun R; Toussaint NC; Fritz CE; Yuan C; Chen H; Rupp NJ; Christiansen A; Rutishauser D; Rüschoff JH; Fankhauser C; Saba K; Poyet C; Hermanns T; Oehl K; Moore AL; Beisel C; Calzone L; Martignetti L; Zhang Q; Zhu Y; Martínez MR; Manica M; Haffner MC; Aebersold R; Wild PJ; Beyer A
Genome Biol; 2020 Dec; 21(1):302. PubMed ID: 33317623
[TBL] [Abstract][Full Text] [Related]
5. Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis.
Zhu W; Liu H; Wang X; Lu J; Zhang H; Wang S; Yang W
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30765615
[No Abstract] [Full Text] [Related]
6. GSTM1 and GSTT1 Polymorphisms and Susceptibility to Prostate Cancer: A Case-Control Study of the Algerian Population.
Benabdelkrim M; Djeffal O; Berredjem H
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2853-2858. PubMed ID: 30362312
[TBL] [Abstract][Full Text] [Related]
7. State of Art of Cancer Pharmacogenomics in Latin American Populations.
López-Cortés A; Guerrero S; Redal MA; Alvarado AT; Quiñones LA
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545225
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
[TBL] [Abstract][Full Text] [Related]
9. Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population.
Al-Achkar W; Azeiz G; Moassass F; Wafa A
Med Oncol; 2014 May; 31(5):889. PubMed ID: 24671854
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies.
Gong M; Dong W; Shi Z; Xu Y; Ni W; An R
PLoS One; 2012; 7(11):e50587. PubMed ID: 23189206
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy.
Cotignola J; Leonardi DB; Shahabi A; Acuña AD; Stern MC; Navone N; Scorticati C; De Siervi A; Mazza O; Vazquez E
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):28-34. PubMed ID: 23146971
[TBL] [Abstract][Full Text] [Related]
12. Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.
Roco A; Quiñones L; Agúndez JA; García-Martín E; Squicciarini V; Miranda C; Garay J; Farfán N; Saavedra I; Cáceres D; Ibarra C; Varela N
Front Genet; 2012; 3():229. PubMed ID: 23130019
[TBL] [Abstract][Full Text] [Related]
13. Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies.
Wei B; Xu Z; Zhou Y; Ruan J; Cheng H; Xi B; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z; Xuan F; Huang X; Zhang J; Zhou H
PLoS One; 2012; 7(10):e46982. PubMed ID: 23071687
[TBL] [Abstract][Full Text] [Related]
14. Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis.
Li H; Xiao D; Hu L; He T
Mol Biol Rep; 2012 Dec; 39(12):10273-84. PubMed ID: 23065259
[TBL] [Abstract][Full Text] [Related]
15. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals.
Cordero K; Espinoza I; Caceres D; Roco A; Miranda C; Squicciarini V; Santander P; Lee K; Saavedra I; Quiñones L
Oncol Lett; 2010 May; 1(3):549-553. PubMed ID: 22966341
[TBL] [Abstract][Full Text] [Related]
16. Estrogens and prostate cancer: etiology, mediators, prevention, and management.
Ho SM; Lee MT; Lam HM; Leung YK
Endocrinol Metab Clin North Am; 2011 Sep; 40(3):591-614, ix. PubMed ID: 21889723
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the Glutathione-S-Transferase P1, M1, and T1 Genotypes and Prostate Cancer Risk in Korean Subjects.
Kwon DD; Lee JW; Han DY; Seo IY; Park SC; Jeong HJ; Yang YS; Chae SC; Na KS; Mo KJ; Kim JJ; Rim JS
Korean J Urol; 2011 Apr; 52(4):247-52. PubMed ID: 21556210
[TBL] [Abstract][Full Text] [Related]
18. Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?
Ashtiani ZO; Hasheminasab SM; Ayati M; Goulian BS; Modarressi MH
Pathol Oncol Res; 2011 Jun; 17(2):269-75. PubMed ID: 21089003
[TBL] [Abstract][Full Text] [Related]
19. Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population.
Thakur H; Gupta L; Sobti RC; Janmeja AK; Seth A; Singh SK
Mol Biol Rep; 2011 Mar; 38(3):1733-9. PubMed ID: 20842440
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
